Exact Sciences competitors, on the record
The companies Exact Sciences names as competitors in its annual reports, 2023 to 2025, and the companies that name Exact Sciences, each with the sentence and the filing.
Who Exact Sciences names
| Company | Named in |
|---|---|
| 3billion | 2025 |
| Agendia Inc. | 2025 |
| Ambry Genetics | 2025 |
| Caris Life Sciences | 2025 |
| Color Health, Inc. | 2025 |
| Delfi | 2025 |
| Freenome | 2025 |
| GeneDx | 2025 |
| GRAIL, Inc. | 2025 |
| Guardant Health, Inc. | 2025 |
| Hologic, Inc. | 2025 |
| Illumina | 2025 |
| Laboratory Corporation of America Holdings (LabCorp) | 2025 |
| Myriad Genetics, Inc. | 2025 |
| Natera | 2025 |
| NeoGenomics | 2025 |
| Personalis | 2025 |
| Quest Diagnostics Incorporated | 2025 |
| Roche Holding, Ltd | 2025 |
| Siemens AG | 2025 |
| Tempus AI | 2025 |
| Variantyx | 2025 |
| Veracyte, Inc. | 2025 |
In its own words
3billion, Ambry Genetics, Color Health, Inc., GeneDx, Illumina, Laboratory Corporation of America Holdings (LabCorp), Myriad Genetics, Inc., Natera, Quest Diagnostics Incorporated, Variantyx
Word for word“We face competition from a variety of sources, including Ambry Genetics (owned by Tempus AI); Myriad Genetics, Inc.; Natera; Color Health, Inc.; GeneDx; Illumina; Variantyx; 3billion; a few large, established general testing companies such as Laboratory Corporation of America Holdings (LabCorp) and Quest Diagnostics Incorporated; and clinical laboratories in an academic or healthcare provider setting that perform clinical genetic testing on behalf of their affiliated institutions.” 10-K for 2025
Agendia Inc., Hologic, Inc., Veracyte, Inc.
Word for word“These companies include Agendia Inc., Veracyte, Inc., Myriad Genetics, Inc., and Hologic, Inc.” 10-K for 2025
Caris Life Sciences, Freenome, GRAIL, Inc., Guardant Health, Inc.
Word for word“These companies include GRAIL, Inc., Guardant Health, Inc., Caris Life Sciences, and Freenome.” 10-K for 2025
Delfi
Word for word“There are multiple companies who have therapy selection products (either tissue-based or blood-based) which compete with the OncoExTra test and our in-development Oncoliquid TM test including Tempus AI, Caris Life Sciences, NeoGenomics, Myriad Genetics, Inc., and Delfi.” 10-K for 2025
NeoGenomics, Personalis, Tempus AI
Word for word“Each of Natera, Tempus AI, Guardant, NeoGenomics, Myriad Genetics, Inc., Quest Diagnostics, and Personalis have commercially available competitive MRD tests or have such tests in development, which currently or may in the future compete directly with our Oncodetect MRD test.” 10-K for 2025
Roche Holding, Ltd, Siemens AG
Word for word“Other potential competitors include companies that develop diagnostic tests such as Roche Holding, Ltd, and Siemens AG, as well as other companies and academic and research institutions.” 10-K for 2025
Who names Exact Sciences
Companies whose own annual reports name Exact Sciences as a competitor.
Word for word“In the field of oncology, we compete with various companies that offer or seek to offer competing solutions, such as BillionToOne Inc.; Caris Life Sciences, Inc.; Exact Sciences Corp.; Guardant Health, Inc.; Personalis, Inc.; Quest; and Tempus Labs, Inc.” 10-K for 2025
Read from Exact Sciences’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-13. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.